Clinical utility of clodronate in the prevention and management of osteoporosis in patients intolerant of oral bisphosphonates
Maurizio Muratore, Eugenio Quarta, Antonella Grimaldi, Fabio Calcagnile, Laura Quarta Department of Rheumatology, Hospital Galateo, San Cesario di Lecce, Italy Abstract: Bisphosphonates have a long history in the treatment of osteoporosis and bone-related disease. This review focuses on the use of a...
Main Authors: | Muratore M, Quarta E, Grimaldi A, Calcagnile F, Quarta L |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2011-10-01
|
Series: | Drug Design, Development and Therapy |
Online Access: | http://www.dovepress.com/clinical-utility-of-clodronate-in-the-prevention-and-management-of-ost-a8503 |
Similar Items
-
The use of bisphosphonates to treat osteoporosis in patients with Lysinuric Protein Intolerance
by: Jos Draaisma, et al.
Published: (2021-04-01) -
Management of cutaneous discomfort in patients with scleroderma: a clinical trial
by: M. Muratore, et al.
Published: (2013-12-01) -
Osteoporosis and diabetes
by: M. Barbagallo, et al.
Published: (2011-09-01) -
Studies of industrial emissions by accelerator-based techniques: A review of applications at CEDAD
by: Calcagnile L., et al.
Published: (2012-04-01) -
Osteonecrosis of the jaw in a patient under treatment of osteoporosis with oral bisphosphonate
by: Marília A. Figueiredo, et al.
Published: (2021-01-01)